Pfizer Pfriends program underway

Share this article:

Pfizer announced that America's uninsured can now obtain Pfizer prescription medicines at significant savings through more than 52,000 community pharmacies nationwide or via Pfizer's mail order service. The savings are available through Pfizer's new program, Pfizer Pfriends.
Enrollment for the program began in August and is ongoing through a toll-free number and Web site.
"We know that paying for prescription medicines can be challenging, especially for those without prescription medicine insurance," said Pfizer chairman and chief executive Hank McKinnell. "Through Pfizer Pfriends, the uninsured don't have to pay full retail price for their Pfizer medicines and can go to almost any retail pharmacy in the country and save money immediately."
Pat Kelly, president of Pfizer U.S. pharmaceuticals, said that being uninsured can make it more difficult to get access to quality health care, and that the uninsured pay more for preventive treatment such as doctor visits and prescription medicines. Pfizer Pfriends can help ease the burden on America's 45 million uninsured by giving them access to prices similar to those paid by large purchasers like major employers and health insurance companies.

 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...